Financhill
Back

Sarepta Therapeutics, Inc. Vs. Pagaya Technologies Ltd. Industry Stock Comparison

Sell
42

SRPT
Sarepta Therapeutics, Inc.

Last Price:
$21.97
Seasonality Move:
10.38%
Buy
54

PGY
Pagaya Technologies Ltd.

Last Price:
$22.68
Seasonality Move:
8.9%
Sell
42
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.23. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Pagaya Technologies Ltd. (PGY) is a Buy

Is Pagaya Technologies Ltd. a Buy, Sell or Hold?

  • The current Pagaya Technologies Ltd. [PGY] share price is $23.30. The Score for PGY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PGY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics, Inc.'s stock price today?

  • The Sarepta Therapeutics, Inc. share price today is $21.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

PGY Stock Price Chart

What is Pagaya Technologies Ltd.'s stock price today?

  • The Pagaya Technologies Ltd. share price today is $23.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGY is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 52.08 Buy
Chaikin Money Flow: 241834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.51 - 22.31) Buy
Bollinger Bands (100): (17.63 - 22.21) Buy

PGY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.09 Buy
Relative Strength Index (14 RSI): 46.6 Sell
Chaikin Money Flow: -507149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.05 - 24.55) Sell
Bollinger Bands (100): (24.05 - 35.43) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.36 Sell
20-day SMA: 21.24 Sell
50-day SMA: 20.76 Buy
200-day SMA: 31.65 Sell
8-day EMA: 13.3 Buy
20-day EMA: 6.91 Buy
50-day EMA: 3.1 Buy
200-day EMA: 0.82 Buy

PGY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.82 Buy
20-day SMA: 23.7 Sell
50-day SMA: 25.23 Sell
200-day SMA: 23.12 Buy
8-day EMA: 14.51 Buy
20-day EMA: 7.53 Buy
50-day EMA: 3.37 Buy
200-day EMA: 0.89 Buy

Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.

Pagaya Technologies Ltd. Earnings Growth & PGY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pagaya Technologies Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):